Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy

A Bringmann1, T Pannicke, V Moll

  • 1Department of Neurophysiology, Paul Flechsig Institute of Brain Research, University of Leipzig, Jahnallee 59, D-04109 Liepzig, Germany. bria@server3.medizin.uni-liepzig.de

Abstract

Insights

Müller cells in proliferative vitreoretinopathy (PVR) show increased P2X(7) receptors, leading to higher calcium entry and potentially driving gliosis. This suggests P2X(7) receptors are key in PVR progression.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Cell Biology

Background:

  • Müller glial cells are crucial retinal support cells.
  • Purinergic receptors, particularly P2X(7), are implicated in cellular responses to injury.
  • Extracellular adenosine triphosphate (ATP) may mediate gliosis, a reactive cell proliferation.

Purpose of the Study:

  • To investigate differences in P2X(7) receptor expression in human Müller cells from healthy donors versus patients with choroidal melanoma and proliferative vitreoretinopathy (PVR).
  • To explore the functional consequences of altered P2X(7) receptor expression on Müller cell activity.

Main Methods:

  • Enzymatic isolation of human Müller cells from donor and patient retinas.
  • Whole-cell patch-clamp recordings to measure P2X(7) currents and Ca2+-activated K+ channels (I:(BK)).
  • Assessment of intracellular calcium concentration changes and DNA synthesis rates.

Main Results:

  • ATP and benzoylbenzoyl ATP (BzATP) stimulated Ca2+ release and P2X(7) channel opening in Müller cells.
  • Müller cells from PVR patients exhibited significantly higher BzATP-evoked cation currents compared to healthy controls.
  • Purinergic agonist stimulation increased DNA synthesis, an effect reversible by blocking I:(BK).

Conclusions:

  • Increased P2X(7) receptor density in PVR Müller cells allows greater extracellular Ca2+ influx.
  • Enhanced Ca2+ entry and subsequent I:(BK) activation may contribute to the proliferative activity of gliotic Müller cells in PVR.
  • P2X(7) receptors represent a potential therapeutic target for managing PVR.

Related Concept Videos